| References: |
LY294002 is a morpholine derivative of quercetin. It is a potent inhibitor of phosphoinositide 3-kinases (PI3Ks). Two of these are the proto-oncogene serine/threonine-protein kinase (PIM1) and the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma iso Form. With an IC50 of 1.4 uM it is somewhat less potent than wortmannin, another well-known PI3 kinase inhibitor However, LY294002 is a reversible inhibitor of PI3K whereas wortmannin acts irreversibly. Application of LY294002 causes a substantial acceleration of MEPP frequency (150 μM) at the frog neuromuscular junction through a mechanism that is independent of intraterminal calcium. LY294002 causes the release of MEPPs through a perturbation of synaptotagmin function. For the detailed information about the solubility of LY294002 in water, the solubility of LY294002 in DMSO, the solubility of LY294002 in PBS buffer, the animal experiment（test） of LY294002,the in vivo,in vitro and clinical trial test of LY294002,the cell experiment（test） of LY294002,the IC50, EC50 and Affinity of LY294002, please contact DC Chemicals. |
